News | February 26, 2026
Envoy Medical secures three new patents, bolstering cochlear implant leadership
The new patents cover critical advancements in cochlear implant technology
The new patents cover critical advancements in cochlear implant technology
Liraglutide is a drug-device combination formulation used in the treatment of chronic weight management
The Phase 2 trial, conducted through Starton’s Sargon Site Network, is expanding from two to six sites across the U.S.
In 2025, over 1 million patients accessed Lilly treatments through LillyDirect
The move follows encouraging Phase I data and a series of regulatory wins from the U.S. Food and Drug Administration
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
The collaboration merges biomodal’s 5-base and 6-base sequencing solutions, duet +modC and duet evoC
To support this launch, ImmunityBio has established a wholly owned subsidiary in Saudi Arabia
Our vision is to position India not just as a consumer of advanced simulation technologies but as a creator and exporter of them
The approval, based on results from the Phase 3 AMPLIFY trial, marks the first all-oral, fixed-duration regimen for first-line CLL therapy
Subscribe To Our Newsletter & Stay Updated
